Fluvoxamine Emergency Use Authorization under FDA consideration.

December 29, 2021

Due to substantive data supporting the use of the antidepressant fluvoxamine for the treatment of COVID-19; university-based researchers are pursuing official FDA emergency-use-authorization for this new use of the drug.

Be the First to Know

Sign up to get updates when we add new off-label treatments, articles, videos, and clinical trials!